Background Previous studies have suggested that breast cancer risk factors are associated
with estrogen receptor (ER) and progesterone receptor (PR) expression status of the tumors. …

Purpose Docetaxel has not been compared with vinorelbine as adjuvant treatment of early
breast cancer. Efficacy and long-term safety of a short course of adjuvant trastuzumab …

Stratification of women according to their risk of breast cancer based on polygenic risk scores
(PRSs) could improve screening and prevention strategies. Our aim was to develop PRSs, …

Hyaluronan (HA) is an extracellular matrix polysaccharide that promotes cell migration
through its cell surface receptors and by effecting changes in the physical environment. HA …

Cancers are supported by a distinct type of connective tissue stroma, crucial for tumor survival
and advancement. Hyaluronan is a major matrix molecule in the stroma of many common …

Aims High amounts of tumour‐associated macrophages ( TAM s) and hyaluronan ( HA )
correlate with tumour aggressiveness in breast cancer, but the relationship between these …

Breast cancers demonstrate substantial biological, clinical and etiological heterogeneity. We
investigated breast cancer risk associations of eight susceptibility loci identified in GWAS …

Importance Trastuzumab plus chemotherapy is the standard adjuvant treatment for patients
with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer. While …

Accumulation of hyaluronan (HA) in pericellular stroma and carcinoma cells is predictive of
unfavorable patient prognosis in many epithelial cancers. However, it is not known whether …

Background Epitheliomesenchymal transition (EMT) is the process where cancer cells attain
fibroblastic features and are thus able to invade neighboring tissues. Transcriptional factors …